Issue of Equity

RNS Number : 1052N
BMO Managed Portfolio Trust PLC
15 May 2020
 

TO:                   RNS

FROM: BMO Managed Portfolio Trust PLC

DATE:              15 May 2020

SUBJECT:        Issue of Equity

LEI:                   213800ZA6TW45NM9YY31

 

 

The Board of BMO Managed Portfolio Trust PLC ("the Company") announces that on 15 May 2020 the Company allotted 50,000 Income shares of £0.094976101 each, from the Company's general business purposes blocklisting facility at a price of 110.50p per Income share and allotted 100,000 Growth shares of £0.094976101 each, from the Company's general purposes blocklisting facility at a price of 197.50p per Growth share. These shares will rank pari passu with the existing Income and Growth shares in issue and dealings are expected to commence on 19 May 2020.

 

Following this issue, the Company has the ability to issue 991,010 Income shares and 791,050 Growth shares under its blocklisting facilities.

 

Following this transaction the Company's issued share capital consists of 46,485,537 Income shares and 35,888,210 Growth shares, of which nil Income shares and nil Growth shares are held in treasury. Therefore the total number of shares with voting rights in BMO Managed Portfolio Trust PLC is 46,485,537 Income shares and 35,888,210 Growth shares.

 

The above figures (46,485,537 Income shares and 35,888,210 Growth shares) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, BMO Managed Portfolio Trust PLC under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Peter Hewitt, BMO Investment Business Limited  0131 718 1244

Ian Ridge, BMO Investment Business Limited  0131 718 1010


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEZELFFBELZBBV
UK 100